Enter your username/e-mail and your new password will be send to you.
| Title | European Life-science Infrastructure for Biological Information |
| Grant Agreement Number | 211601 |
| Funding Programmes | FP7 |
| Dates | 01/11/2007 - 31/12/2012 |
| Project URL | http://www.elixir-europe.org |
| Scientific Domain |
Biological and Medical Sciences |
| Action Line | Preparatory phase |
| Type Of Project | CP-CSA-INFRA |
| Abstract | The objective of the ELIXIR preparatory phase is to produce a memorandum or memoranda of understanding between organisations (government agencies, research councils, funding bodies and scientific organisations) within the member states, with the purpose of constructing a world class and globally positioned European infrastructure for the management and integration of information in the life sciences. To achieve this, we will address the following tasks and issues: 1 Define the scope of the infrastructure, its role and benefits 2 Define an appropriate governance and legal structure 3 Define a long term funding structure to provide a sustainable infrastructure 4 Define the requirements for the European Data Centre in the next 5-10 years and makes plans to meet these needs 5 Involve all relevant stakeholders, including users, data providers, tools providers to ensure that the infrastructure meets their needs 6 Explore integration and interoperability between core and specialised data resources and the development of standards in newly emerging fields 7 Define the critical interdisciplinary links that need to be forged between the biological and related scientific disciplines, including medicine, agriculture and the environment 8 Define the needs of related European industries 9 Define a training strategy to ensure that Europe effectively exploits all the available information The specific activities of the preparatory phase will include: A Holding stakeholder meetings to bring together national representatives, key scientific opinion and funding organisations. B Establishing working parties, supported by technical feasibility studies where appropriate, to address the tasks and issues above with final reports at month 18. C Consolidating these reports into a management and funding proposal to be sent to member states and funding agencies with draft MoU by month 38 and to seek agreement on the MoU and establish an Interim ELIXIR Board by month 50. D To establish the detailed organization of ELIXIR; and to draft and work toward the signing of the ELIXIR International Consortium Agreement |
|
Partners
(Organisation name and Country) |
Technical University of Denmark, Denmark INSTITUT NATIONAL DE RECHERCHE EN INFORMATIQUE ET AUTOMATIQUE, France SWISS INSTITUTE OF BIOINFORMATICS, Switzerland GENOME RESEARCH LIMITED, United Kingdom TECHNISCHE UNIVERSITAET BRAUNSCHWEIG, Germany MEDICAL RESEARCH COUNCIL, United Kingdom MAGYAR TUDOMANYOS AKADEMIA SZEGEDI BIOLOGIAI KOZPONT ENZIMOLOGIAI INTEZET, Hungary LINKOPINGS UNIVERSITET, Sweden ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM, Netherlands The Swedish Research Council - Vetenskapsrȯdet, Sweden German Federal Ministry of Education and Research, Germany THE ISRAELI MINISTRY OF SCIENCE, CULTURE AND SPORT, Israel NEDERLANDSE ORGANISATIE VOOR WETENSCHAPPELIJK ONDERZOEK, Netherlands THE WELLCOME TRUST LIMITED, United Kingdom UNIVERSITE VICTOR SEGALEN BORDEAUX II, France SARDEGNA RICERCHE, Italy THE ICELANDIC CENTRE FOR RESEARCH, Iceland DEUTSCHE FORSCHUNGSGEMEINSCHAFT, Germany CENTRO DI RICERCA, SVILUPPO E STUDI SUPERIORI IN SARDEGNA, Italy FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III, Spain RESEARCH CENTRE FOR NATURAL SCIENCES, HUNGARIAN ACADEMY OF SCIENCES, Hungary FUNDACION PARA EL DESAROLLO DE LA INVESTIGACION EN GENOMICA Y PROTEOMICA, Spain STICHTING KATHOLIEKE UNIVERSITEIT, Netherlands SYNGENTA LIMITED, United Kingdom BIOTECHNOLOGY AND BIOLOGICAL SCIENCES RESEARCH COUNCIL, United Kingdom |
| Related Documents |
Safeguarding the results of life science research in Europe
|
